Stephen M. Beard

Expertise

Health Economics
Disease Management
Decision Analytic Modeling and Value Strategy Development in Health Care

Biography

Stephen Beard heads heath economic and European operations based in the RTI-HS office in Manchester, UK. He has more than 20 years of experience in the application of mathematical modeling and decision analysis within academic, government, and industrial organizations. His work involves the management of projects using health economic and statistical modeling techniques to explore disease progression and the impact of treatment across a range of areas, including oncology and infectious disease. He is a member of the International Society of Pharmacoeconomics Outcomes Research, and has presented and published in numerous conferences and peer-reviewed journals, including European Journal of Health Economics, British Journal of Cancer, and Pharmacoeconomics. He was previously responsible for leading a team that produced a rapid review health technology appraisal report for the National Institute for Health and Clinical Excellence in the UK.

Education

MSc, Operational Research, University of Birmingham, UK; BSc, Mathematics, University of London, UK.

Selected Publications

Beard, S.M., Maciver, F., Clouth, J., & Ruther, E. (2006 Sept). A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany. European Journal of Health Economics, 7 (3):165-172.

Legendre, C., Beard, S.M., Crochard, A., Lebranchu, Y., Pouteil-Noble, C., Richter, A., & Durand-Zaleski, I. (2005). The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation. European Journal of Health Economics, 6 (2):172-182.

Beard, S.M., Wall, L., Gaffney, L., & Sampson, F. (2004). Aggressive non-Hodgkin's lymphoma: economics of high-dose therapy. Pharmacoeconomics, 22 (4):207-224.

Beard, S., Hunn, A., & Wight, J. (2003). Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technology Assessment, 7 (40: iii, ix-x):1-111.

Paisley, S., Beard, S., Hunn, A., & Wight, J. (August 2002). Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review. Multiple Sclerosis, 8 (4):319-329.

Stevenson, M., Beard, S., Finn, A., & Brennan, A. (March 2002). Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule. Vaccine, 20 (13-14):1778-1786.

Richards, R.G., Sampson, F.C., Beard, S.M., & Tappenden, P. (2002). A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technology Assessment, 6 (10):1-73.

Sampson, F.C., Beard, S.M., Scott, F., & Vandenberghe, E. (2001 Jun). Cost-effectiveness of high-dose chemotherapy in first-line treatment of advanced multiple myeloma. British Journal of Haematology, 113 (4):1015-1019.

Stevenson, M.D., Oakley, P.A., Beard, S.M., Brennan, A., & Cook, A.L. (May 2001). Triaging patients with serious head injury: results of a simulation evaluating strategies to bypass hospitals without neurosurgical facilities. Injury, 32 (4):267-274.

View all publications by Stephen M. Beard…